November 1-3, 2024
General Session #1: The role of tumor classification in optimizing therapy and outcomes
General Session #2: Imaging as a predictive biomarker in clinical trials early endpoint
General Session #3: Increasing efficacy while decreasing toxicity of local and systemic therapy
General Session #4: Risk Prediction and Biomarkers for Prevention Trials
General Session #5: Applying the lessons of breast cancer biology to prevention
General Session #6: The Consequences of the Dobbs decision: a look at the impact in women’s health
General Session #8: Equitable Access: Tackling Barriers in Clinical Trial Diversity
General Session #9: Lecture: The Science of the Sex Hormone Ecosystem Across a Woman's Lifespan
General Session #10: Postpartum Breast Cancer: Opportunities for Improving Treatment and Prevention
General Session #11: Making Prevention and Holistic Care a Priority in Women’s Health
